The prognostic significance of disease features at the time of diagnosis was examined in 113 patients (75 males/38 females, median age 49 years) with chronic myeloid leukemia (CML) using multivariate regression analysis. In the course of this study we tested the validity of the prognostic model described by Sokal and coworkers(3), the predictive value of histopathological variables, and determined the disease-specific loss in life expectancy. The median survival time was 35 months in our patients. By using Cox's proportional hazards model for covariate analysis of censored survival data(26)'(32) two prognostic models were derived. The first consisted of the following parameters-age, presence of pseudo-Gaucher cells in the marrow, spleen size and the product of myeloblasts and normoblasts in the peripheral blood. The second model included age, the presence of myelofibrosis, the number of megakaryocytes in the bone marrow and the liver size. Both models provided a risk status that showed an excellent predictive relationship to relative survival rates and life expectancy. Application of the Sokal model(3) to our subpopulation of CML patients failed to reveal a significant segregation of the intermediate group from the other risk groups, even when assessing the disease-specific loss in life expectancy. Our results suggest that an amendment of the generally accepted model for prognostic evaluation of survival in CML should be made by inclusion of histological variables and the determination of relative survival rates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/10428199109107059 | DOI Listing |
Neurosurgery
January 2025
Division of Neurosurgery, Changi General Hospital, Singapore.
Background And Objective: The global average life expectancy has been increasing steadily as the quality of healthcare continues to improve. However, there is a paucity of data looking at surgical fixation of thoracolumbar spine fractures in patients ≥80 years (super-elderly). Aim of this study is to look at whether there is higher rate of complications from surgical fixation of thoracolumbar fractures in this group of patients.
View Article and Find Full Text PDFEur J Neurol
February 2025
Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
Background And Purpose: This study aims to assess the disease burden and care quality along with cross-country inequalities for stroke at global, regional, and national levels from 1990 to 2021.
Methods: Data on stroke were extracted from the Global Burden of Disease (GBD) study 2021 for the globe, five sociodemographic index (SDI) regions, 21 GBD regions, and 204 countries/territories. The disease burden was quantified using the age-standardized disability-adjusted life years rate (ASDR).
Cancer Med
February 2025
Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.
Background: Male breast cancer (MBC) is rare and often treated using evidence from female breast cancer (BC) trials due to limited male participation. Previous estimates lacked global coverage and completeness. We aimed to quantify the global MBC burden from 1990 to 2021 and evaluate its current status and trends.
View Article and Find Full Text PDFInt J Clin Health Psychol
January 2025
Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Department of Psychology, Rio de Janeiro, RJ, Brazil.
Objectives: With increasing global life expectancy, cognitive interventions hold promise in mitigating cognitive decline and fostering healthy aging. Despite the demand for evidence-based interventions, there have been few attempts to summarize existing evidence. This study aims to assess the effectiveness and feasibility of unimodal and multimodal cognitive interventions for cognitively healthy older adults.
View Article and Find Full Text PDFDiabetol Int
January 2025
Department of Clinical Nutrition, National Hospital Organization Kyoto Medical Center, 1-1Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, 612-8555 Japan.
Background: This study aimed to compare the economic value of intermittent-scanning continuous glucose monitoring (isCGM) with self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes (T1D).
Methods: Participants were placed on either an isCGM or SMBG arm for 84 days, in a randomized, crossover setup with a 28-day washout period. Clinically relevant hypoglycemia (<54 mg/dL) and severe hypoglycemia (SH) risks were calculated by analyzing the data from isCGM.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!